MDxHealth signs diagnostic deal with Merck KGaA

BRUSSELS (Reuters) – Diagnostics maker MDxHealth SA said on Thursday one of its tests will be developed alongside a cancer drug being developed by Germany’s Merck KGaA to help identify people who will benefit most from being given the treatment.